Kamunting Street Capital Management, L.P. Bristol Myers Squibb CO Transaction History

Kamunting Street Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $1.34 Million - $1.56 Million	-25,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $1.48 Million - $1.73 Million	25,000 New	25,000 $1.48 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $1.15 Million - $1.27 Million	-20,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $1.1 Million - $1.28 Million	20,000 New	20,000 $1.18 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $4.72 Million - $5.6 Million	-110,436 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $2.25 Million - $2.49 Million	50,436 Added 84.06%	110,436 $5.01 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $2.71 Million - $3.23 Million	60,000 New	60,000 $2.86 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Kamunting Street Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Kamunting Street Capital Management, L.P. with notifications on news.